Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (221-230 of 349) with videos related to

Pageof 35
Sort By:
European Urology|December 7, 2007
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomyMichael Müntener, Jonathan I Epstein, David J Hernandez, et al.
Reviews in Urology|January 6, 2018
Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MAMaria J Arcila-Ruiz, Dean G Assimos, Benjamin M Brucker, et al.
The Journal of Urology|October 12, 2005
Obesity and capsular incision at the time of open retropubic radical prostatectomyStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
BJU International|October 14, 2011
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot studyHerbert Lepor, Carol D Cheli, Robert P Thiel, et al.
Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.
The Journal of Urology|August 12, 2005
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral centerStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
Cancer|December 12, 2003
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomyMasood A Khan, Patrick C Walsh, M Craig Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.
The Journal of Urology|December 17, 2009
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance programJeffrey J Tosoian, Stacy Loeb, Anna Kettermann, et al.
Pageof 35

Showing results (221-230 of 349) with videos related to

Sort By:
Pageof 35
European Urology|December 7, 2007
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomyMichael Müntener, Jonathan I Epstein, David J Hernandez, et al.
Reviews in Urology|January 6, 2018
Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MAMaria J Arcila-Ruiz, Dean G Assimos, Benjamin M Brucker, et al.
The Journal of Urology|October 12, 2005
Obesity and capsular incision at the time of open retropubic radical prostatectomyStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
BJU International|October 14, 2011
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot studyHerbert Lepor, Carol D Cheli, Robert P Thiel, et al.
Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.
The Journal of Urology|August 12, 2005
Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral centerStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.
Cancer|December 12, 2003
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomyMasood A Khan, Patrick C Walsh, M Craig Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.
The Journal of Urology|December 17, 2009
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance programJeffrey J Tosoian, Stacy Loeb, Anna Kettermann, et al.
Pageof 35